Background: Heart failure is a major worldwide health concern and leading cause of mortality. RNAi interventions hold promise for patients resistant to conventional drugs due to their off-target effects and lack of specificity.
Objectives: To examine the safety and effectiveness of RNAi therapeutics in treating heart failure.